Re: Re: spms III human trials this fall

[Guest guest]

Or are we back to the theory that MS isn't a disease but a collection of diseases that cause similar symptoms?

----- Original Message -----

From: Reg Kreil

low dose naltrexone

Sent: Tuesday, July 13, 2004 7:25 AM

Subject: Re: [low dose naltrexone] Re: spms III human trials this fall

So if minocycline the antibiotic helps with M.S. Then could this be a different disease other than M.S,like Lymes disease? Or could someone have both,and the Dr.s only see the M.S. try to treat the M.S. have not so good results and fail to see the underlying Lymes disease?

Just a thought.

Reg

-------Original Message-------

From: low dose naltrexone

Date: 07/13/04 07:54:03

low dose naltrexone

Subject: Re: [low dose naltrexone] Re: spms III human trials this fall

Minocyline is an antibiotic that has been helpful for some people. Here is a website with some info:

http://www.thisisms.com/article112.html

----- Original Message -----

From: Johanne F

low dose naltrexone

Sent: Tuesday, July 13, 2004 6:34 AM

Subject: [low dose naltrexone] Re: spms III human trials this fall

Tom,would you know if minocycline is the same product that you talk about here? The reason I ask is because my neuro Dr Jack Antel in MS research in Montreal, quebec spoke to me about a drug that seems very promising co9ming out of Alberta. Also I know a person from France who's doctor gives him this drug. He said it comes from Alberta and is experimental. So I'm wondering if there is a connection among all this info. thank you.> > And right here in Edmonton, too. Dr. Warren is my neuro, and I have ppms. I sure hope it helps that too.......> > MBP8298, Product ... MBP). MBP8298 has been developed for the treatment of> multiple sclerosis (MS), and is based on over 26 years of research. ... > www.biomsmedical.com/MBP8298info.asp - 8k - Cached - Similar pages > I didn't now if any of you knew of this or not.> > Tom from EDMONTON>

____________________________________________________ IncrediMail - Email has finally evolved - Click Here